In this behind-the-scenes episode, we talk with Austin Flohrschutz, the Science Director for TruPotency.com, a CBD retailer that performs extensive third party testing on CBD products to screen for fraudulent or mislabeled products. At the time that we spoke, Austin informed me that they had tested 400 products, and 30% of those products passed testing. The vast majority of failures were for mislabeled potency. Around 0.5% failed for contaminants like heavy metals or residual solvents.
Through this conversation we discuss the extent of CBD product fraud in the market, what TruPotency has seen regarding CBD product quality, issues related to cannabinoid testing, research into the psychedelic Salvinorin A from Salvia divinorum and implications for alternative opioid therapies, and much more.
Enjoy and stay curious!
Web | Facebook | Instagram | Twitter | YouTube